The percentage of IL-17A-producing T cells from SLE patients was higher than that from healthy controls; the increased percentage was abolished by transfected JKAP but not JKAP phosphatase-dead mutant (Figure 1C). This evidence concerns the gene IL17A and systemic lupus erythematosus.